Crewe Advisors’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-45	Closed	-$257	–	927
2023 Q1	$257	Hold	45	–	–	﹤0.01%	788
2022 Q4	$454	Hold	45	–	–	﹤0.01%	974
2022 Q3	$1K	Hold	45	–	–	﹤0.01%	1139
2022 Q2	$1K	Buy	+45	New	+$1K	﹤0.01%	1061